Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01565447 · ClinicalTrials.gov registry record
Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 109
- Enrollment target
NCT01565447 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 109 participants.
The verdict
NCT01565447 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 109 participants
- Enrollment target
Study Summary
This purpose of this study it to characterize the walking patterns of children diagnosed with Acute Lymphoblastic Leukemia (ALL)and Lymphoblastic Lymphoma (LL) at different times in the treatment protocol and after completion of treatment. Their walking patterns will be compared to children without ALL or LL to see if their walking patterns are different at specific times in their treatment program or up to 10 years after completion of their treatment. The investigators will gather data by observing how the child walks, runs, hops on one foot and climbs stairs and by recording walking patterns on a pressure sensitive mat. The investigators will compare this data to children without ALL and LL.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2011-12 |
| Est. Completion | 2023-03-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01565447
The ClinicalTrials.gov registry entry for NCT01565447 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01565447 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01565447 about?
NCT01565447 is a clinical study titled "Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study". This purpose of this study it to characterize the walking patterns of children diagnosed with Acute Lymphoblastic Leukemia (ALL)and Lymphoblastic Lymphoma (LL) at different times in the treatment protocol and after completion of treatment. Their walking patterns will be compared to children without ...
What is the current status of trial NCT01565447?
This trial is currently completed. The enrollment target is 109 participants. The study started on 2011-12. Estimated completion is 2023-03-20.
Who is sponsoring clinical trial NCT01565447?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.